European CHMP recommends approval of fostemsavir (Rukobia) for treatment of multidrug resistant HIV-1 infection

Fostemsavir is an oral antiviral that selectively inhibits the interaction between HIV and cellular CD4 receptors, thereby preventing viral entry into the host cells.

Source:

European Medicines Agency